Mutual of America Capital Management LLC Raises Stake in Agilent Technologies, Inc. (NYSE:A)

Mutual of America Capital Management LLC grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 0.3% during the 3rd quarter, HoldingsChannel reports. The fund owned 50,306 shares of the medical research company’s stock after acquiring an additional 160 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Agilent Technologies were worth $7,469,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Western Pacific Wealth Management LP lifted its stake in shares of Agilent Technologies by 18.9% in the 1st quarter. Western Pacific Wealth Management LP now owns 440 shares of the medical research company’s stock valued at $64,000 after acquiring an additional 70 shares during the last quarter. Menard Financial Group LLC boosted its stake in shares of Agilent Technologies by 1.6% during the second quarter. Menard Financial Group LLC now owns 4,845 shares of the medical research company’s stock valued at $628,000 after purchasing an additional 77 shares during the period. McAdam LLC grew its holdings in shares of Agilent Technologies by 3.1% in the third quarter. McAdam LLC now owns 2,531 shares of the medical research company’s stock worth $376,000 after purchasing an additional 77 shares during the last quarter. Global Retirement Partners LLC increased its stake in shares of Agilent Technologies by 3.2% in the third quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company’s stock worth $382,000 after buying an additional 79 shares during the period. Finally, Rovin Capital UT ADV raised its holdings in Agilent Technologies by 1.6% during the 3rd quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock valued at $750,000 after buying an additional 81 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on A shares. UBS Group boosted their price objective on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. TD Cowen increased their price objective on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Barclays boosted their target price on Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research note on Tuesday, October 15th. Evercore ISI raised their price target on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. Finally, Bank of America boosted their price objective on shares of Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $144.36.

Insider Buying and Selling

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the transaction, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. The trade was a 7.51 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. This trade represents a 19.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 11,995 shares of company stock worth $1,739,510 in the last quarter.

Agilent Technologies Trading Down 0.1 %

NYSE:A opened at $126.92 on Tuesday. The firm has a market capitalization of $36.47 billion, a P/E ratio of 26.33, a PEG ratio of 5.59 and a beta of 1.07. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. Agilent Technologies, Inc. has a one year low of $112.39 and a one year high of $155.35. The company’s 50-day simple moving average is $138.50 and its 200 day simple moving average is $137.92.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the previous year, the firm posted $1.43 EPS. The business’s revenue for the quarter was down 5.6% compared to the same quarter last year. As a group, analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were given a $0.236 dividend. This represents a $0.94 annualized dividend and a dividend yield of 0.74%. The ex-dividend date was Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is presently 19.50%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.